Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Nanobiotix has finalized a non-dilutive royalty sharing financing agreement with Healthcare Royalty, securing an initial $50 million cash inflow.
On Monday, November 24, 2025, Nanobiotix announced the completion of its non-dilutive financing agreement with Healthcare Royalty for up to $71 millio…
Nanobiotix continued its upward trajectory this Monday, November 17, at the Paris Stock Exchange. The biotechnology company's stock closed at 19.56 eu…
Nanobiotix has announced the filing of four new patent applications for its Curadigm nanoprimer platform, thereby expanding its intellectual property.
Biotechnology company Nanobiotix will take part in a discussion at the Jefferies London Healthcare Conference, according to a company announcement.
This morning, the French biotech stock is regaining ground at the Paris Stock Exchange, showing a clear recovery after a strongly bearish session at t…
NANOBIOTIX shows solid progress this Monday, gaining 8.81% and surpassing the 18.50 euro mark mid-session. After experiencing a significant decline ea…
This morning, the biotech stock regained its footing at €16.52, marking a new attempt at stabilization after a tumultuous week. This recovery comes am…
The French biotech company regains momentum on Tuesday morning at the Paris Stock Exchange, driven by a technical rebound after six consecutive sessio…
French biotech company Nanobiotix sees a resurgence on Tuesday at the Paris Stock Exchange, marking a significant recovery after an extremely tumultuo…
